bezafibrate has been researched along with Liver Diseases, Alcoholic in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Banerjee, A; Lee, JH; Ramaiah, SK; Ueno, Y | 1 |
Dou, X; Gu, D; Li, S; Shen, C; Song, Z; Wang, Z; Yao, T | 1 |
Barve, S; Bradford, BU; Chawla, RK; Colell, A; Deaciuc, I; Enomoto, N; Fernandez-Checa, JC; Garcia-Ruiz, C; Hill, D; Hirose, M; Ikejima, K; Ishii, H; Ishikawa, M; Joshi-Barve, S; Kaplowitz, N; Kitamura, T; Konno, A; Kono, H; Lin, M; McClain, CJ; Motomura, K; Nakamura, Y; Nelson, W; Ohata, M; Oide, H; Okamura, Y; Peter, S; Rivera, CA; Sato, N; Schmidt, J; Shimizu, H; Takei, Y; Thurman, R; Tsukamoto, H; Watson, W; Yamashina, S; Yokoyama, H | 1 |
1 review(s) available for bezafibrate and Liver Diseases, Alcoholic
Article | Year |
---|---|
How is the liver primed or sensitized for alcoholic liver disease?
Topics: Animals; Bezafibrate; Endotoxins; Gene Expression; Hepatocytes; Humans; Hypolipidemic Agents; Iron; Kupffer Cells; Liver; Liver Diseases, Alcoholic; Mitochondria, Liver; Peroxisome Proliferators; S-Adenosylmethionine; Superoxides; Tretinoin; Tumor Necrosis Factor-alpha | 2001 |
2 other study(ies) available for bezafibrate and Liver Diseases, Alcoholic
Article | Year |
---|---|
Potential relationship between hepatobiliary osteopontin and peroxisome proliferator-activated receptor alpha expression following ethanol-associated hepatic injury in vivo and in vitro.
Topics: Acetaldehyde; Animals; Bezafibrate; Bile Ducts; Cell Line, Tumor; Disease Models, Animal; Epithelial Cells; Ethanol; Hepatocytes; Humans; Lipopolysaccharides; Liver; Liver Diseases, Alcoholic; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Osteopontin; PPAR alpha; Rats; Rats, Sprague-Dawley; RNA, Messenger; Transcription, Genetic; Transfection | 2008 |
Inhibition of NF-κB activation by 4-hydroxynonenal contributes to liver injury in a mouse model of alcoholic liver disease.
Topics: Acetylcysteine; Aldehydes; Animals; Bezafibrate; Caspases; Cell Death; Cytoprotection; Disease Models, Animal; Enzyme Activation; Ethanol; Hep G2 Cells; Hepatocytes; Humans; I-kappa B Proteins; JNK Mitogen-Activated Protein Kinases; Liver; Liver Diseases, Alcoholic; Male; Mice; Mice, Inbred C57BL; NF-kappa B; NF-KappaB Inhibitor alpha; Phosphorylation; Time Factors; Transcriptional Activation; Tumor Necrosis Factor-alpha | 2012 |